Levodopa prodrug mesylate, crystalline form thereof, pharmaceutical composition comprising it, uses thereof, methods of preparation thereof and methods of preparing crystalline form thereof

摘要

(2R)-2-Phenylcarbonyloxypropyl (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate mesylate and crystalline form thereof, methods of making the same, pharmaceutical compositions thereof, and methods of using the same to treat diseases or disorders such as Parkinson's disease are provided.